Dataset from A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006801
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the anti-tumor activity of SU011248 (sunitinib) in cytokine-refractory metastatic
renal cell carcinoma (RCC) when administered in a continuous treatment regimen
创建时间：
2025-11-07
